Predicting factors for valproate treatment outcome among bipolar II patients – focused on GNB3 and CRP level
碩士 === 國立成功大學 === 臨床藥學與藥物科技研究所 === 103 === Background: Valproate (VPA) is a mood stabilizer for the treatment of bipolar II disorder (BD II) patients, but it may cause metabolic disturbances in certain patients. Genetic and environmental factors may involve in individual difference of metabolic dist...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/34226213863851959735 |